For the first time since its IPO, SpaceX's president plans to sell 340,000 shares, cashing out over $52 million.

SpaceX has seen its first executive share reduction signal since its IPO, with President and Chief Operating Officer Gwynne Shotwell planning to sell over $52 million worth of stock. The timing, just before Starship's first orbital test, has brought the market's disagreement about the company's high valuation back to the forefront.

Regulatory filings show that Shotwell plans to sell 342,170 shares, worth approximately $51.96 million, acquired through cash-based stock options. Meanwhile, another financial disclosure reveals that an investment account held in the name of US President Trump engaged in short-swing trading of SpaceX stock in July, further raising concerns about insider trading.

SPCX shares rose about 2% on Tuesday, closing at $154.72, ending a two-day losing streak.

The above disclosure comes ahead of a crucial window for SpaceX's planned 14th Starship flight, scheduled for no earlier than September 28th. The mission will be the first attempt to launch the upper stage into Earth orbit and deploy 26 Starlink V3 satellites. The success or failure of the test will directly impact market expectations for SpaceX's commercialization progress and will also have a potential impact on the stock price.

The 10b5-1 plan safeguards compliance in share reduction.

Shotwell's decision to reduce his holdings was not impulsive.

In its first quarterly report since its IPO, SpaceX disclosed that it adopted a 10b5-1 transaction plan on June 23, covering up to 585,605 shares. The number of shares listed in this sale notice does not exceed the disclosure limit of the plan, and the company also stated that most of its holdings are still under extended lock-up periods.

The 10b5-1 plan is a compliance tool under U.S. securities law that allows company insiders to pre-arrange stock trading activities. It aims to isolate trading from the acquisition of inside information in time, thereby avoiding insider trading charges. Since this plan was adopted before the Starship testing window was determined, from a legal perspective, this share reduction has a clear compliance basis.

However, analysts point out that there is a gap between compliance and market perception. Given the company's high valuation and the uncertainty surrounding Starship's commercial prospects, executive share reductions are often interpreted by the market as an implicit assessment of short-term stock price, even if the transaction itself complies with regulations.

Trump's short-term account transactions raise questions about potential conflicts of interest.

In contrast to Shotwell's planned reduction of holdings, the investment account held in Trump's name exhibited more controversial short-term trading characteristics. Disclosure documents show that the account bought between $15,001 and $50,000 worth of SpaceX stock on July 10, and subsequently sold between $1,001 and $15,000 worth on July 17; previous disclosures also showed that the account made purchases on June 23.

White House spokesman Davis Ingles responded, "President Trump and none of his family members have the ability to direct, influence, or advise on how investments are made or when they are bought or sold."

Nevertheless, the aforementioned transactions have still attracted widespread attention. SpaceX holds important contracts with NASA and the U.S. Department of Defense, and as the highest decision-maker in the government, Trump's accounts holding and trading the company's stock naturally pose a perceived risk of potential conflict of interest. For retail investors, the trading behavior of insiders—whether company executives or politically affiliated accounts—is often seen as a reference signal for judging stock trends, thus affecting their confidence in holding positions.

Starship Orbital Test: A Key Moment to Validate Overestimation

The timing of this share reduction disclosure highly coincides with one of SpaceX's most important technological milestones.

The company plans to conduct Starship's 14th flight no earlier than September 28. The mission objective is to send the upper stage into Earth orbit for the first time, orbit the Earth six times during the 10-hour flight, deploy 26 active Starlink V3 satellites, and finally splash down in the Pacific Ocean.

This is Starship's most commercially significant test to date. SpaceX is gradually shifting its launch focus from the Falcon 9 to Starship, and some commercial customers are finding it difficult to book Falcon 9 launches beyond 2028, seeking alternatives instead. The company has begun reducing Falcon 9 production capacity, but the rocket is expected to remain in service for many more years, especially in government missions, to bridge the gap in Starship's development.

If this orbital insertion test is successfully completed, it will provide strong support for SpaceX's Starship commercialization narrative and underpin its current high valuation. Conversely, if the test encounters a major mishap, it could trigger a reassessment of the company's technology roadmap and profitability timeline, putting downward pressure on the stock price. Given the already released signals of executives reducing their holdings, the marginal impact of the test results on investor sentiment will be further amplified.

High growth expectations coexist with uncertainties.

Since its IPO, SpaceX's stock performance has been supported by strong market expectations regarding its monopolistic position in commercial spaceflight and the profitability potential of its Starlink business. However, the sale of shares by executives has made the market's divergence in opinions regarding the current valuation level more apparent.

Supporters argue that once Starship achieves large-scale commercial operation, it will completely reshape the global launch market landscape, and its current valuation is forward-looking and reasonable. Critics, however, point out that Starship has a long development cycle and high technological risks; there is a transition period risk between the reduction in Falcon 9 production capacity and Starship commercialization; and the fact that executives chose to cash out their shares on the eve of a key test is itself a market signal.

For retail investors, finding a balance between insider trading signals, the uncertainty of technical tests, and long-term growth narratives will be the core consideration in portfolio decisions.

Risk warning and disclaimerInvesting involves risk; please exercise caution. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Any investment decisions made based on this information are at your own risk.